Abstract
Aberrant aggregation of proteins into poorly soluble, toxic structures that accumulate intracellularly or extracellularly leads to a range of disease states including Alzheimer’s, Parkinson’s, Huntington’s, prion diseases, and type II diabetes. Many of the disease-associated amyloidogenic proteins are intrinsically disordered, which makes their experimental investigation challenging due to a limited number of experimental observables to effectively characterize their ensemble of conformations. Molecular dynamics simulations provide dynamic information with atomistic detail, and are increasingly employed to study aggregation processes, offering valuable structural and mechanistic insights. In this chapter, we demonstrate the use of all-atom molecular dynamics simulations to model the self-aggregation of a six-residue amyloidogenic peptide derived from amyloid β, a 39–43 residue-long peptide associated with the pathogenesis of Alzheimer’s disease. We provide detailed instructions on how to obtain the initial monomer conformations and build the multichain systems, how to carry out the simulations, and how to analyze the simulation trajectories to investigate the peptide self-aggregation process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eisenberg D, Nelson R, Sawaya MR, Balbirnie M, Sambashivan S, Ivanova MI, Madsen AØ, Riekel C (2006) The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc Chem Res 39:568–575
Aguzzi A, O'Connor T (2010) Protein aggregation diseases: Pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9:1–12
Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366
Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Rev 10:S10–S17
DeToma AS, Salamekh S, Ramamoorthy A, Lim MH (2012) Misfolded proteins in Alzheimer's disease and type II diabetes. Chem Soc Rev 41:608–621
Ishimaru D, Andrade LR, Teixeira L, Quesado PA, Maiolino LM, Lopez PM, Cordeiro Y, Costa LT, Heckl WM, Weissmuller G, Foguel D, Silva JL (2003) Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemist 42:9022–9027
Rigacci S, Bucciantini M, Relini A, Pesce A, Gliozzi A, Berti A, Stefani M (2008) The (1–63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies. Biophys J 94:3635–3646
Silva JL, Rangel LP, Costa DCF, Cordeiro Y, De Moura Gallo CV (2013) Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor. Biosci Rep 33:593–603
Yang-Hartwich Y, Soteras MG, Lin ZP, Holmberg J, Sumi N, Craveiro V, Liang M, Romanoff E, Bingham J, Garofalo F, Alvero A, Mor G (2014) p53 protein aggregation promotes platinum resistance in ovarian cancer. Oncogene 34:3605–3616
Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV (2006) Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem 281:13828–13836
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448–6453
Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97:571–576
Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ (2001) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy. Am J Pathol 159:1993–2000
Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507–511
Anderluh G, Gutirrez-Aguirre I, Rabzelj S, Čeru S, Kopitar-Jerala N, Maček P, Turk V, Žerovnik E (2005) Interaction of human stefin B in the prefibrillar oligomeric form with membranes. FEBS J 272:3042–3051
Rabzelj S, Viero G, Gutiérrez-Aguirre I, Turk V, Dalla Serra M, Anderluh G, Žerovnik E (2008) Interaction with model membranes and pore formation by human stefin B - studying the native and prefibrillar states. FEBS J 275:2455–2466
Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci U S A 95:4224–4228
Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A 96:3590–3594
Kusumoto Y, Lomakin A, Teplow DB, Benedek GB (1998) Temperature dependence of amyloid β-protein fibrillization. Proc Natl Acad Sci U S A 95:12277–12282
Zurdo J, Guijarro JI, Jiménez JL, Saibil HR, Dobson CM (2001) Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. J Mol Biol 311:325–340
Marek PJ, Patsalo V, Green DF, Raleigh DP (2012) Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects. Biochemist 51:8478–8490
West MW, Wang W, Patterson J, Mancias JD, Beasley JR, Hecht MH (1999) De novo amyloid proteins from designed combinatorial libraries. Proc Natl Acad Sci U S A 96:11211–11216
Hecht MH (1994) De novo design of β-sheet proteins. Proc Natl Acad Sci U S A 91:8729–8730
Rousseau F, Schymkowitz J, Serrano L (2006) Protein aggregation and amyloidosis: confusion of the kinds? Curr Opin Struct Biol 16:118–126
Fernandez-Escamilla A-M, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22:1302–1306
Rauscher S, Baud S, Miao M, Keeley FW, Pomes R (2006) Proline and glycine control protein self-organization into elastomeric or amyloid fibrils. Structure 14:1667–1676
Uversky VN, Oldfield CJ, Dunker AK (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys 37:215–246
Dobson CM (2004) Experimental investigation of protein folding and misfolding. Methods 34:4–14
Best RB (2017) Computational and theoretical advances in studies of intrinsically disordered proteins. Curr Opin Struct Biol 42:147–154
Gerben SR, Lemkul JA, Brown AM, Bevan DR (2014) Comparing atomistic molecular mechanics force fields for a difficult target: a case study on the Alzheimer’s amyloid β-peptide. J Biomol Struct Dyn 32:1817–1832
Piana S, Donchev AG, Robustelli P, Shaw DE (2015) Water dispersion interactions strongly influence simulated structural properties of disordered protein states. J Phys Chem B 119:5113–5123
Hoffmann KQ, McGovern M, Chiu C-C, de Pablo JJ (2015) Secondary structure of rat and human amylin across force fields. PLoS One 10:e0134091
Henriques J, Cragnell C, Skepö M (2015) Molecular dynamics simulations of intrinsically disordered proteins: force field evaluation and comparison with experiment. J Chem Theory Comput 11:3420–3431
Rauscher S, Gapsys V, Gajda MJ, Zweckstetter M, de Groot BL, Grubmüller H (2015) Structural ensembles of intrinsically disordered proteins depend strongly on force field: a comparison to experiment. J Chem Theory Comput 11:5513–5524
Carballo-Pacheco M, Strodel B (2016) Comparison of force fields for Alzheimer's Aβ42: a case study for intrinsically disordered proteins. Protein Sci 26:174–185
Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, Grubmüller H, MacKerell AD (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71–73
Larini L, Shea J-E (2012) Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25–35) peptide. Biophys J 103:576–586
Matthes D, Gapsys V, Brennecke JT, de Groot BL (2016) An atomistic view of amyloidogenic self-assembly: structure and dynamics of heterogeneous conformational states in the pre-nucleation phase. Sci Rep 6:33156
Li G, Pomes R (2013) Binding mechanism of inositol stereoisomers to monomers and aggregates of Aβ(16–22). J Phys Chem B 117:6603–6613
Nguyen PH, Derreumaux P (2013) Conformational ensemble and polymorphism of the all-atom Alzheimer’s Aβ37–42 amyloid peptide oligomers. J Phys Chem B 117:5831–5840
Baftizadeh F, Biarnes X, Pietrucci F, Affinito F, Laio A (2012) Multidimensional view of amyloid fibril nucleation in atomistic detail. J Am Chem Soc 134:3886–3894
Barz B, Olubiyi OO, Strodel B (2014) Early amyloid β-protein aggregation precedes conformational change. Chem Commun 50:5373–5375
Rauscher S, Pomes R (2017) The liquid structure of elastin. elife 6:e26526–e26521
Sasmal S, Schwierz N, Head-Gordon T (2016) Mechanism of nucleation and growth of Aβ40 fibrils from all-atom and coarse-grained simulations. J Phys Chem B 120:12088–12097
Wagoner VA, Cheon M, Chang I, Hall CK (2014) Impact of sequence on the molecular assembly of short amyloid peptides. Proteins 82:1469–1483
Bieler NS, Knowles TPJ, Frenkel D, Vácha R (2012) Connecting macroscopic observables and microscopic assembly events in amyloid formation using coarse grained simulations. PLoS Comput Biol 8:e1002692
Wood SJ, Wetzel R, Martin JD, Hurle MR (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemist 34:724–730
Colletier J-P, Laganowsky A, Landau M, Zhao M, Soriaga AB, Goldschmidt L, Flot D, Cascio D, Sawaya MR, Eisenberg D (2011) Molecular basis for amyloid-β polymorphism. Proc Natl Acad Sci U S A 108:16938–16943
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Humphrey W, Dalke A, Schulten K (1996) VMD: Visual Molecular Dynamics. J Mol Graph 14:33–38
Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2:19–25
MacKerell AD Jr, Bashford D, Bellott M, Dunbrack RL Jr, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616
Paci E, Karplus M (2000) Unfolding proteins by external forces and temperature: the importance of topology and energetics. Proc Natl Acad Sci U S A 97:6521–6526
Mayor U, Johnson CM, Daggett V, Fersht AR (2000) Protein folding and unfolding in microseconds to nanoseconds by experiment and simulation. Proc Natl Acad Sci U S A 97:13518–13522
Day R, Bennion BJ, Ham S, Daggett V (2002) Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. J Mol Biol 322:189–203
Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Miyamoto S, Kollman PA (1992) SETTLE: An analytical version of the SHAKE and RATTLE algorithm for rigid water molecules. J Comput Chem 13:952–962
Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101
Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690
Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190
Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22:2577–2637
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Meneksedag-Erol, D., Rauscher, S. (2019). Atomistic Simulation Tools to Study Protein Self-Aggregation. In: McManus, J. (eds) Protein Self-Assembly. Methods in Molecular Biology, vol 2039. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9678-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9678-0_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9677-3
Online ISBN: 978-1-4939-9678-0
eBook Packages: Springer Protocols